Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
96 studies found for:    Open Studies | "Heparin"
Show Display Options
Rank Status Study
21 Recruiting A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
Conditions: Acute Kidney Injury;   Acute Renal Failure;   Heart Failure
Interventions: Drug: Dilute unfractionated heparin;   Drug: Standard concentration unfractionated heparin
22 Recruiting Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients
Conditions: Critical Ill Patients;   Patients Needing Continuous Renal Replacement Therapy
Interventions: Device: AN69ST hemofilter;   Device: AN69 hemofilter
23 Not yet recruiting Thoracic Surgery Extended Low-Molecular Weight Heparin VTE Prophylaxis--Pilot Trial
Conditions: Venous Thromboembolism;   Lung Neoplasms;   Pulmonary Embolism
Interventions: Drug: LMWH: Dalteparin;   Other: Placebo
24 Recruiting Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
Conditions: Deep Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Low dose nadroparin;   Drug: Intermediate dose nadroparin;   Drug: Low dose enoxaparin;   Drug: Intermediate dose enoxaparin;   Drug: Low dose dalteparin;   Drug: Intermediate dose dalteparin;   Drug: Fixed low dose tinzaparin;   Drug: Intermediate dose tinzaparin
25 Unknown  Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
Condition: Chronic Renal Failure
Intervention: Biological: heparin sodium
26 Recruiting Pregnancy Outcomes in Women With Recurrent Miscarriage Treated With Low Dose Aspirin and Unfractionated Heparin
Condition: Recurrent Miscarriage
Intervention: Drug: Heparin
27 Unknown  The Role of Low Molecular Weight Heparins (LMWH) Combined With Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: LMWH;   Procedure: TACE
28 Unknown  Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Cancer
Intervention: Drug: low molecular weight heparin
29 Recruiting Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)
Condition: Infertility
Interventions: Drug: Enaoxaprin sodium;   Drug: tissue culture media
30 Recruiting Clinical Outcomes About Heparin Surface Modified Aspheric Lens
Condition: Inflammatory Reaction
Interventions: Device: traditional lens;   Device: heparin surface modified aspheric lens
31 Recruiting The Use of Low Molecular Weight Heparin in Hemodiafiltration
Condition: Chronic Kidney Disease
Interventions: Procedure: At start of the session, at the inlet line;   Procedure: 5 minutes after the start of the session, at the inlet line;   Procedure: At the start of the session, at the outlet line
32 Unknown  Impact of Heparin on the Need for Mechanical Ventilation in Neonates
Conditions: Respiration, Artificial;   Hemorrhage
Intervention: Drug: heparin
33 Recruiting Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU
Condition: Patients With Acute Renal Insufficiency
Interventions: Drug: Citrate 4%;   Drug: unfractionated heparin
34 Recruiting Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
Condition: Septic Shock
Interventions: Drug: Anticoagulation to prevent clotting of the extracorporeal circuit. (regional citrate anticoagulation);   Drug: Anticoagulation to prevent clotting of the extracorporeal circuit (Unfractionated heparin)
35 Unknown  Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
Conditions: Venous Thrombosis;   Pulmonary Embolism
Intervention: Drug: Enoxaparin
36 Recruiting Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
Conditions: ST-segment Elevation Myocardial Infarction;   Non ST-segment Elevation Myocardial Infarction
Interventions: Drug: bivalirudin;   Drug: Heparin
37 Unknown  Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients
Conditions: Cancer;   Thrombosis;   Angina Pectoris;   Advanced Solid Malignancy
Intervention:
38 Unknown  Effect of a Pre Heparin Coated Dialysis Filter on Coagulation During Hemodialysis
Condition: Renal Failure
Intervention: Device: a pre-heparin-coated hemodialysis filter; Hepran
39 Unknown  Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?
Condition: Fetal Growth Retardation
Interventions: Drug: Innohep (Tinzaparin);   Drug: tinzaparin
40 Unknown  Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery
Condition: Acquired Platelet Function Disorder
Intervention: Device: Balance surface, Carmeda heparin-coated surface

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years